¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"infection control study"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
case-control study
ȯÀÚ´ëÁ¶±º¿¬±¸, »ç·Ê´ëÁ¶±º¿¬±¸
hospital infection control
º´¿ø°¨¿°°ü¸®
infection control surveillance
°¨¿°°ü¸®°¨½Ã
laboratory infection control
°Ë»ç½Ç°¨¿°°ü¸®
nosocomial infection control
º´¿ø³»°¨¿°°ü¸®
air study
°ø±âÁÖÀÔ°Ë»ç
cohort study
ÄÚȣƮ¿¬±¸, ÄÚȣƮÁ¶»ç
controlled clinical study
°ü¸®ÈÀÓ»ó½ÃÇè
crossover study
±³Â÷¿¬±¸
cross-sectional study
´Ü¸é¿¬±¸
case comparison study
ȯÀÚ´ëÁ¶±º¿¬±¸
case referent study
ȯÀÚ´ëÁ¶±º¿¬±¸
case study
Áõ·Ê¿¬±¸, »ç·ÊÁ¶»ç
diachronic study
ºñµ¿½Ã¿¬±¸
double blind study
ÀÌÁ߸Ͱ˿¬±¸
´ÙÀ½
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
case-control study
ȯÀÚ´ëÁ¶±º¿¬±¸
control
1. ÅëÁ¦, Á¦¾î, 2. ´ëÁ¶, 3. °ü¸®
quality control
Á¤µµ°ü¸®, ǰÁú°ü¸®, Áú°ü¸®
reflex control
¹Ý»çÁ¶Àý
safety control
¾ÈÀü°ü¸®
sugar control
Ç÷´çÁ¶Àý
impulse control disorder
Ãæµ¿Á¶ÀýÀå¾Ö, Ãæµ¿Á¶Àýº´
study design
¿¬±¸¼³°è
study
¿¬±¸, °Ë»ç, Á¶»ç
arterial blood gas study
µ¿¸ÆÇ÷°¡½ººÐ¼®
cohort study
ÄÚȣƮ¿¬±¸
cross-sectional study
´Ü¸éÁ¶»ç¿¬±¸
ecological study
»ýÅ¿¬±¸
longitudinal study
ÃßÀû¿¬±¸
observational study
°üÂû¿¬±¸
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
1
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
infection control study
°¨¿°°ü¸®Á¶»ç
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
case-control study
(¢¡retrospective) ÈÄÇ⿬±¸, µÞ¹æÇ⿬±¸
hospital infection control
º´¿ø°¨¿°°ü¸®
laboratory infection control
°Ë»ç½Ç°¨¿°°ü¸®
nosocomial infection control
¿ø³»°¨¿°°ü¸®
infection control surveillance
°¨¿°°ü¸®°¨½Ã
air study
°ø±âÁÖÀÔ°Ë»ç
arterial blood gas study
µ¿¸ÆÇ÷°¡½ººÐ¼®
cardiac gated MR study
½ÉÀ嵿±âÀÚ±â°ø¸í°Ë»ç
case study
Áõ·Ê¿¬±¸
case comparison study
ȯÀÚ´ëÁ¶±º¿¬±¸
case compeer study
ȯÀÚ´ëÁ¶±º¿¬±¸
case referent study
ȯÀÚ´ëÁ¶±º¿¬±¸
case-base study
ȯÀÚ¸ðÁý´Ü¿¬±¸
cohort study
(¢¡prospective) °èȹ¿¬±¸, ÀüÇ⿬±¸, ¾Õ¹æÇ⿬±¸
controlled clinical study
°ü¸®ÈÀÓ»ó½ÃÇè
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
1
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
infection control study
°¨¿°°ü¸®¿¬±¸
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
hospital infection control
¿ø³»<º´¿ø>°¨¿°°ü¸®
infection control surveillance
°¨¿°°ü¸®°¨½Ã
B cell study
B ¼¼Æ÷°Ë»ç
air study
°ø±â(ÁÖÀÔ) °Ë»ç(¹ý)
arterial blood gas study
µ¿¸ÆÇ÷ °¡½ººÐ¼®
phase 1 study
ÀÓ»óÁ¦1»ó½ÃÇè.
pilot study
¿¹ºñ½ÇÇè.
population study
Àα¸Á¶»ç
preclinical study
ÀüÀÓ»ó½ÃÇè(îñìúßÉãËúÐ).
pressure flow study
¾Ð·ù·® Á¶»ç
pressure-perfusion study
¾Ð·Â°ü·ù°Ë»ç
prospective study
°èȹÀû¿¬±¸, ÀüÇâÀû¿¬±¸
real time study
½Ç½Ã°£ °Ë»ç
AGC (automatic gain control)
ÀÚµ¿ °ÔÀÎ Á¶Àý
AGC (automatic gain control)
ÀÚµ¿ (í»ÔÑ) °ÔÀÎ Á¶Àý (ðàï½), À̵æÀÚµ¿Á¶Àý
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
1
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
infection control study
°¨¿°°ü¸®¿¬±¸
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
case control study
ȯÀÚ´ëÁ¶¿¬±¸.
nested case control study
hospital infection control
¿ø³»<º´¿ø>°¨¿°°ü¸®
infection control surveillance
°¨¿°°ü¸®°¨½Ã
laboratory infection control
°Ë»ç½Ç°¨¿°°ü¸®
nosocomial infection control
¿ø³»°¨¿°°ü¸®
air study
°ø±â(ÁÖÀÔ) °Ë»ç(¹ý)
arterial blood gas study
µ¿¸ÆÇ÷ °¡½ººÐ¼®
cardiac gated MR study
½ÉÀ嵿±â ÀÚ±â°ø¸í °Ë»ç
case study
Áõ·Ê¿¬±¸(Áõ¿¹¿¬±¸).
case study
Áõ·Ê¿¬±¸(ñøçÓæÚϼ).
cohort study
ÄÚ¿ÀÆ®¿¬±¸(ÊÙËçË´), Æø·ÎºñÆø·Î¿¬±¸.
controlled clinical study
(Ãß°èÇÐÀû) °ü¸®È(̧ËÌ°ËøË´ËöÌ´)(ÀÓ»ó)½ÃÇè( ËöË×ËàÌ´).
double-blind study
ÀÌÁ߸ͰË.
family study
°¡Á·Á¶»ç(¿¬±¸)
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
ÅëÇÕ°Ë»ö ¿Ï·á
´ÙÀ½